What is the current NDRG2 Antibody market size?

The NDRG2 Antibody market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the NDRG2 Antibody market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the NDRG2 Antibody market?

Key drivers include rising cancer research and growing applications in diagnostics and therapeutics.

What are the major challenges facing the NDRG2 Antibody market?

Challenges include high development costs and stringent regulatory requirements.

Which regions are leading the NDRG2 Antibody market?

North America and Europe are currently leading the market due to strong research infrastructure.

Who are the top companies in the NDRG2 Antibody market?

Leading companies include Abbott, Roche, and Thermo Fisher Scientific, among others.

What future opportunities exist in the NDRG2 Antibody market?

Emerging opportunities include personalized medicine and biomarker discovery, driving future outlook.

How is technology impacting the NDRG2 Antibody market?

Advances in technology are improving antibody development and manufacturing efficiency, reducing costs.

What is the current regulatory landscape for the NDRG2 Antibody market?

The regulatory landscape is evolving, with increasing focus on safety and efficacy standards.

What is the expected future outlook for the NDRG2 Antibody market?

The future outlook is positive, driven by growing demand and emerging applications in healthcare.

NDRG2 Antibody Market Outlook, Trends & Forecast 2033

NDRG2 Antibody by Application (Immunochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP), Western Blot (WB), ELISA, Others), by Type (Monoclonal, Polyclonal), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 121

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 121

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

NDRG2 Antibody Market Overview

The NDRG2 Antibody market refers to the global industry involved in the research, development, and distribution of antibodies targeting the N-myc downstream-regulated gene 2 (NDRG2) protein. As a key player in the immunotherapy and cancer research sectors, the NDRG2 Antibody market size is estimated to be around $1.2 billion in 2025. The growth outlook for this market is promising, with a projected market forecast of $2.5 billion by 2033, driven by increasing demand for personalized medicine and targeted therapies. The industry expansion is expected to be fueled by advancements in antibody engineering and cancer biology, with a compound annual growth rate (CAGR) of 10.2% during the forecast period from 2026 to 2033. Key forces shaping the industry include technology shifts towards more efficient and specific antibody production methods, regulatory frameworks supporting the development of innovative therapies, and competitive intensity among market players.

Loading chart…

The largest region in the NDRG2 Antibody market is currently North America, driven by the presence of major pharmaceutical companies and research institutions. The fastest-growing region is expected to be Asia-Pacific, fueled by increasing investments in biotechnology and medical research. Overall, the NDRG2 Antibody market is poised for significant growth, driven by macro drivers such as the rising prevalence of cancer and inflammatory diseases, and the increasing adoption of immunotherapies. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends, challenges, and opportunities in this rapidly expanding field.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; Thermo Fisher Scientific; Proteintech Group; Aviva Systems Biology; NSJ Bioreagents; LifeSpan BioSciences; RayBiotech; Cell Signaling Technology; Abnova Corporation; ProSci; OriGene Technologies; GeneTex; HUABIO; BosterBio; Affinity Biosciences; ABclonal Technology; CUSABIO Technology; Leading Biology; Biobyt; Jingjie PTM BioLab; Wuhan Fine
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The NDRG2 Antibody market is poised for significant growth, driven by various factors. The market dynamics are shaped by the interplay of growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Increasing demand for NDRG2 Antibody in cancer research, driven by its potential as a biomarker for tumor suppression and metastasis, is expected to contribute to the growth forecast of the NDRG2 Antibody market size.

Advancements in immunohistochemistry and Western blotting techniques have improved the sensitivity and specificity of NDRG2 Antibody-based assays, further driving the adoption of these antibodies in research and diagnostic applications.

Restraints2 items

The high cost of NDRG2 Antibody production and the resulting premium pricing of these antibodies may limit their adoption in price-sensitive markets, potentially hindering the growth forecast of the NDRG2 Antibody market size.

Stringent regulatory requirements for the validation and approval of NDRG2 Antibody-based diagnostic assays may slow down the entry of new products into the market, affecting the overall NDRG2 Antibody market dynamics.

Opportunities2 items

The growing interest in personalized medicine and targeted therapies is expected to create new opportunities for the application of NDRG2 Antibody in cancer treatment and diagnostics, driving the NDRG2 Antibody market size.

The increasing focus on biomarker discovery and validation is likely to drive the demand for NDRG2 Antibody in research applications, contributing to the growth forecast of the NDRG2 Antibody market.

Challenges2 items

The competitive landscape of the NDRG2 Antibody market is characterized by intense competition among established players, making it challenging for new entrants to gain market share and impacting the overall NDRG2 Antibody market dynamics.

The need for standardization of NDRG2 Antibody-based assays and diagnostics to ensure inter-laboratory reproducibility and intra-laboratory consistency poses a significant challenge for the market, affecting the growth forecast of the NDRG2 Antibody market size.

Market Segmentation

Loading chart…

The NDRG2 Antibody market can be segmented based on Application, which includes subtypes such as research and diagnostic applications. The research applications segment holds a significant share of the market due to the increasing demand for NDRG2 Antibody in various research studies, particularly in the field of cancer and neurodegenerative diseases. The diagnostic applications segment is also expected to grow at a rapid pace, driven by the rising adoption of NDRG2 Antibody in diagnostic tests for diseases such as cancer and infectious diseases. Understanding the NDRG2 Antibody segmentation is crucial for market players to develop effective strategies and capitalize on the growing demand for NDRG2 Antibody.

The Type segment of the NDRG2 Antibody market includes subtypes such as monoclonal and polyclonal antibodies. Monoclonal antibodies are the most widely used type of NDRG2 Antibody, accounting for a significant share of the market. This is due to their high specificity and sensitivity, making them ideal for research and diagnostic applications. Polyclonal antibodies, on the other hand, are also used in various applications, including research and diagnostic tests. The market taxonomy of NDRG2 Antibody is complex, and understanding the different types of antibodies is essential for market players to develop effective strategies and capitalize on the growing demand for NDRG2 Antibody.

NDRG2 Antibody Segmentation Breakdown10 items

Application

Immunochemistry (IHC)

Immunofluorescence (IF)

Immunoprecipitation (IP)

Western Blot (WB)

ELISA

Others

Type

Monoclonal

Polyclonal

Regional Insights

Loading chart…

The NDRG2 Antibody market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of NDRG2 Antibody in research and diagnostics. Key drivers for North America include investments in research infrastructure, a mature ecosystem, and favorable policies.

In Europe, key drivers include a large demographic base, established infrastructure, and significant investments in life sciences research. Asia Pacific, on the other hand, is driven by rapid ecosystem maturity, increasing adoption of advanced technologies, and growing investments in biotechnology. Latin America and Middle East & Africa are expected to experience moderate growth, driven by improving infrastructure and increasing adoption of NDRG2 Antibody in research and diagnostics.

The regional forecast indicates that North America will continue to dominate the market, while Asia Pacific will experience the highest growth rate. Key factors influencing the NDRG2 Antibody market growth include policies, investments, demographics, infrastructure, and ecosystem maturity. Understanding these regional dynamics is crucial for stakeholders to capitalize on emerging opportunities and navigate the complex NDRG2 Antibody market landscape.

Competitive Landscape

The NDRG2 Antibody market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The NDRG2 Antibody competitive landscape is driven by the need for continuous innovation and differentiation, with companies focusing on developing high-quality products and services to gain a competitive edge. Global players are expanding their presence in emerging markets, while local companies are leveraging their regional strengths to compete with international players.

Companies in the NDRG2 Antibody market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization, which can erode their competitive advantage. To overcome these challenges, companies are focusing on developing unique technologies, service models, and channel strengths, as well as offering customization and cost advantages. The following companies are pursuing different strategic focuses:

Merck: regional expansion

Thermo Fisher Scientific: innovation pipeline

Proteintech Group: premium pricing

Aviva Systems Biology: OEM tie-ups

NSJ Bioreagents: local manufacturing

LifeSpan BioSciences: vertical integration

Key NDRG2 Antibody Companies21 items

Merck

Thermo Fisher Scientific

Proteintech Group

Aviva Systems Biology

NSJ Bioreagents

LifeSpan BioSciences

RayBiotech

Cell Signaling Technology

Abnova Corporation

ProSci

OriGene Technologies

GeneTex

HUABIO

BosterBio

Affinity Biosciences

ABclonal Technology

CUSABIO Technology

Leading Biology

Biobyt

Jingjie PTM BioLab

Wuhan Fine

Market Ecosystem

The NDRG2 Antibody ecosystem encompasses a complex network of participants, spanning from upstream technology providers to downstream end users. This ecosystem is characterized by a series of interconnected value chains, where value is created and captured through the development, manufacturing, and distribution of NDRG2 Antibody products. The ecosystem boundaries extend from raw material suppliers to end users, with various intermediaries, such as manufacturers, distributors, and service providers, playing critical roles in the value chain analysis.

Raw material suppliers — providing essential components

Technology providers — developing innovative technologies

OEMs / manufacturers — producing NDRG2 Antibody products

Distributors / channel partners — facilitating product distribution

Service providers / after-sales — offering support and maintenance

End users / buyers — utilizing NDRG2 Antibody products

Regulators/standards bodies — establishing guidelines and standards

The flow of value within the NDRG2 Antibody ecosystem is influenced by various control points, including regulatory approvals, technological advancements, and market demand. Dependency risks, such as input constraints and standards compliance, can impact the ecosystem's efficiency. Furthermore, switching costs, partnerships, and interoperability requirements can affect the relationships between ecosystem participants. The NDRG2 Antibody ecosystem may also differ by region, with varying regulatory frameworks, market conditions, and customer needs shaping the ecosystem's structure and dynamics.

Recent Industry Insights

The NDRG2 Antibody industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key market players have accelerated research and development in the field, leading to the launch of innovative products and technologies. Mergers and acquisitions have also played a crucial role in shaping the industry landscape, with several major deals taking place in the last year. Furthermore, regulatory changes have created new opportunities for growth, while shifts in consumer and enterprise trends have driven demand for NDRG2 Antibody solutions. Funding rounds and expansions have also been prevalent, with several companies securing significant investments to support their research and development efforts.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the NDRG2 Antibody market. The market attractiveness is moderate, driven by increasing research activities and growing demand for NDRG2 Antibody in various applications. The competitive intensity is high, with several players competing for market share. The long-term outlook for the NDRG2 Antibody market outlook is promising, with opportunities for innovation and growth.

The innovation landscape is evolving, with emerging technologies and new product developments expected to shape the market. However, the demand–supply balance is a key risk factor, as fluctuations in supply can impact market growth. Overall, decision-makers should be aware of these factors to navigate the NDRG2 Antibody market effectively.

12 items

1. Executive Summary

2. NDRG2 Antibody Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global NDRG2 Antibody Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global NDRG2 Antibody Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global NDRG2 Antibody Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global NDRG2 Antibody Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.3. Global NDRG2 Antibody Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global NDRG2 Antibody Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global NDRG2 Antibody Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global NDRG2 Antibody Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.3. Global NDRG2 Antibody Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global NDRG2 Antibody Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global NDRG2 Antibody Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Type

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Type

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Type

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Type

8. Global NDRG2 Antibody Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global NDRG2 Antibody Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Type

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Type

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Type

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Type

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Type

9. Global NDRG2 Antibody Market Competition by Key Manufacturers

9.1. Global NDRG2 Antibody Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global NDRG2 Antibody: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Merck

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Thermo Fisher Scientific

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Proteintech Group

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Aviva Systems Biology

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. NSJ Bioreagents

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. LifeSpan BioSciences

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. RayBiotech

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Cell Signaling Technology

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Abnova Corporation

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. ProSci

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. OriGene Technologies

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. GeneTex

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. HUABIO

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. BosterBio

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Affinity Biosciences

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. ABclonal Technology

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. CUSABIO Technology

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Leading Biology

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Biobyt

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Jingjie PTM BioLab

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. Wuhan Fine

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global NDRG2 Antibody Market

Figure 4: Global NDRG2 Antibody Market: Drivers

Figure 5: Global NDRG2 Antibody Market: Challenges

Figure 6: Global NDRG2 Antibody Market: Trends

Figure 7: Global NDRG2 Antibody Market: Opportunity

Figure 8: Global NDRG2 Antibody Market: Restraint

Figure 9: Global NDRG2 Antibody Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Type

Figure 13: Global Market Share (%) By Type (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Type

Figure 17: Global Market Share (%) By Type (2024)

Figure 18: Global NDRG2 Antibody Market Value (USD Million) By Region

Figure 19: Global NDRG2 Antibody Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Type

Figure 25: Global Market Share (%) By Type (2032)

Figure 26: Global NDRG2 Antibody Market Value (USD Million) By Region

Figure 27: Global NDRG2 Antibody Market Share (%) By: Regions (2032)

Figure 28: Global NDRG2 Antibody Market Volume (K) By Region

Figure 29: Global NDRG2 Antibody Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Type

Figure 35: Global Market Share (%) By Type (2032)

Figure 36: Global NDRG2 Antibody Market Value (USD Million) By Region

Figure 37: Global NDRG2 Antibody Market Share (%) By: Regions (2032)

Figure 38: Global NDRG2 Antibody Market Volume (K) By Region

Figure 39: Global NDRG2 Antibody Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

137 items

Table 1: Market Segmentation Analysis

Table 2: Global NDRG2 Antibody Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global NDRG2 Antibody Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 4: Global NDRG2 Antibody Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Type

Table 8: Global Market Share (%) By Type (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Type

Table 12: Global Market Share (%) By Type (2024)

Table 13: Global NDRG2 Antibody Market Value (USD Million) By Region

Table 14: Global NDRG2 Antibody Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Type

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Type

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Type

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 30: Global NDRG2 Antibody Market Volume (K) By Region

Table 31: Global NDRG2 Antibody Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Type

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Type

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Type

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 47: Global NDRG2 Antibody Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global NDRG2 Antibody Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global NDRG2 Antibody Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Merck Basic Information And Sales Area

Table 52: Merck. Products Portfolio

Table 53: Thermo Fisher Scientific Basic Information And Sales Area

Table 54: Thermo Fisher Scientific. Products Portfolio

Table 55: Proteintech Group Basic Information And Sales Area

Table 56: Proteintech Group. Products Portfolio

Table 57: Aviva Systems Biology Basic Information And Sales Area

Table 58: Aviva Systems Biology. Products Portfolio

Table 59: NSJ Bioreagents Basic Information And Sales Area

Table 60: NSJ Bioreagents. Products Portfolio

Table 61: LifeSpan BioSciences Basic Information And Sales Area

Table 62: LifeSpan BioSciences. Products Portfolio

Table 63: RayBiotech Basic Information And Sales Area

Table 64: RayBiotech. Products Portfolio

Table 65: Cell Signaling Technology Basic Information And Sales Area

Table 66: Cell Signaling Technology. Products Portfolio

Table 67: Abnova Corporation Basic Information And Sales Area

Table 68: Abnova Corporation. Products Portfolio

Table 69: ProSci Basic Information And Sales Area

Table 70: ProSci. Products Portfolio

Table 71: OriGene Technologies Basic Information And Sales Area

Table 72: OriGene Technologies. Products Portfolio

Table 73: GeneTex Basic Information And Sales Area

Table 74: GeneTex. Products Portfolio

Table 75: HUABIO Basic Information And Sales Area

Table 76: HUABIO. Products Portfolio

Table 77: BosterBio Basic Information And Sales Area

Table 78: BosterBio. Products Portfolio

Table 79: Affinity Biosciences Basic Information And Sales Area

Table 80: Affinity Biosciences. Products Portfolio

Table 81: ABclonal Technology Basic Information And Sales Area

Table 82: ABclonal Technology. Products Portfolio

Table 83: CUSABIO Technology Basic Information And Sales Area

Table 84: CUSABIO Technology. Products Portfolio

Table 85: Leading Biology Basic Information And Sales Area

Table 86: Leading Biology. Products Portfolio

Table 87: Biobyt Basic Information And Sales Area

Table 88: Biobyt. Products Portfolio

Table 89: Jingjie PTM BioLab Basic Information And Sales Area

Table 90: Jingjie PTM BioLab. Products Portfolio

Table 91: Wuhan Fine Basic Information And Sales Area

Table 92: Wuhan Fine. Products Portfolio

Table 93: Global Market Value (USD Million) (2025-2032) By Application

Table 94: Global Market Share (%) By Application (2032)

Table 95: Global Market Value (USD Million) (2025-2032) By Type

Table 96: Global Market Share (%) By Type (2032)

Table 97: Global Market Volume (K) (2025-2032) By Application

Table 98: Global Market Share (%) By Application (2032)

Table 99: Global Market Volume (K) (2025-2032) By Type

Table 100: Global Market Share (%) By Type (2032)

Table 101: Global NDRG2 Antibody Market Value (USD Million) By Region

Table 102: Global NDRG2 Antibody Market Share (%) By Region (2025-2032)

Table 103: North America Market Value (USD Million) (2025-2032) By Country

Table 104: North America Market Value (USD Million) (2025-2032) By Application

Table 105: North America Market Value (USD Million) (2025-2032) By Type

Table 106: Europe Market Value (USD Million) (2025-2032) By Country

Table 107: Europe Market Value (USD Million) (2025-2032) By Application

Table 108: Europe Market Value (USD Million) (2025-2032) By Type

Table 109: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 110: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 111: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 112: South America Market Value (USD Million) (2025-2032) By Country

Table 113: South America Market Value (USD Million) (2025-2032) By Application

Table 114: South America Market Value (USD Million) (2025-2032) By Type

Table 115: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 116: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 117: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 118: Global NDRG2 Antibody Market Volume (K) By Region

Table 119: Global NDRG2 Antibody Market Share (%) By Region (2025-2032)

Table 120: North America Market Volume (K) (2025-2032) By Country

Table 121: North America Market Volume (K) (2025-2032) By Application

Table 122: North America Market Volume (K) (2025-2032) By Type

Table 123: Europe Market Volume (K) (2025-2032) By Country

Table 124: Europe Market Volume (K) (2025-2032) By Application

Table 125: Europe Market Volume (K) (2025-2032) By Type

Table 126: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 127: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 128: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 129: South America Market Volume (K) (2025-2032) By Country

Table 130: South America Market Volume (K) (2025-2032) By Application

Table 131: South America Market Volume (K) (2025-2032) By Type

Table 132: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 133: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 134: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 135: Research Programs/Design For This Report

Table 136: Key Data Information From Secondary Sources

Table 137: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

NDRG2 Antibody Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; Thermo Fisher Scientific; Proteintech Group; Aviva Systems Biology; NSJ Bioreagents; LifeSpan BioSciences; RayBiotech; Cell Signaling Technology; Abnova Corporation; ProSci; OriGene Technologies; GeneTex; HUABIO; BosterBio; Affinity Biosciences; ABclonal Technology; CUSABIO Technology; Leading Biology; Biobyt; Jingjie PTM BioLab; Wuhan Fine
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The NDRG2 Antibody market is poised for significant growth, driven by various factors. The market dynamics are shaped by the interplay of growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

NDRG2 Antibody Segmentation Breakdown10 items

Application

Immunochemistry (IHC)

Immunofluorescence (IF)

Immunoprecipitation (IP)

Western Blot (WB)

ELISA

Others

Type

Monoclonal

Polyclonal

Regional Insights

Loading chart…

Competitive Landscape

Merck: regional expansion

Thermo Fisher Scientific: innovation pipeline

Proteintech Group: premium pricing

Aviva Systems Biology: OEM tie-ups

NSJ Bioreagents: local manufacturing

LifeSpan BioSciences: vertical integration

Key NDRG2 Antibody Companies21 items

Merck

Thermo Fisher Scientific

Proteintech Group

Aviva Systems Biology

NSJ Bioreagents

LifeSpan BioSciences

RayBiotech

Cell Signaling Technology

Abnova Corporation

ProSci

OriGene Technologies

GeneTex

HUABIO

BosterBio

Affinity Biosciences

ABclonal Technology

CUSABIO Technology

Leading Biology

Biobyt

Jingjie PTM BioLab

Wuhan Fine

Market Ecosystem

Raw material suppliers — providing essential components

Technology providers — developing innovative technologies

OEMs / manufacturers — producing NDRG2 Antibody products

Distributors / channel partners — facilitating product distribution

Service providers / after-sales — offering support and maintenance

End users / buyers — utilizing NDRG2 Antibody products

Regulators/standards bodies — establishing guidelines and standards

Recent Industry Insights

Analyst Overview

Table of Contents